Trial Search

Current Search Criteria:

Intervention: CERE-120: AAV2-NTN
Found 3 matching trials

Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease

PHASE2

The purpose of this double blind study is to determine whether CERE-120 (ad...

Status

Completed

Location

University of Alabama, Birmingham

Start Date

2006-11

Trial ID

NCT00400634

Treatments Being Tested

CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])Sham Surgery

Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease

PHASE1

The purpose of this study was to evaluate the safety and potential benefits...

Status

Completed

Location

University of Alabama at Birmingham

Start Date

2009-10-29

Trial ID

NCT00985517

Treatments Being Tested

CERE-120: Adeno-Associated Virus Delivery of NeurturinSham Surgery

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

PHASE1

This is a Phase I dose escalating open-label study designed to assess the s...

Status

Completed

Location

University of California, San Francisco

Start Date

2005-06

Trial ID

NCT00252850

Treatments Being Tested

CERE-120: AAV2-NTN
PreviousNext